(Q33953931)

English

Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Rieke Alten

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Juan Gomez-Reino

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Patrick Durez

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Andre Beaulieu

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anthony Sebba

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gerhard Krammer

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ralph Preiss

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Udayasankar Arulmani

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Albert Widmer

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Xavier Gitton

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Herbert Kellner

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

7 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

BMC Musculoskeletal Disorders

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

153

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The pathogenesis of bone erosions in gouty arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

Update on biology: uric acid and the activation of immune and inflammatory cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

Use of canakinumab in the cryopyrin-associated periodic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

Anakinra for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152943

5 July 2018

Joint counts in routine practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21736751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21736751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21736751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21736751

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2474-12-153

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33953931&oldid=2196048338"